If you or a loved one has been diagnosed with EGFR positive, metastatic non-small cell lung cancer (NSCLC), you’re already facing a lot of decisions. These may include what type of treatment will work best for you. You and your doctor can work ...
In the time since IMBRUVICA® (ibrutinib) was first approved by the FDA in 2013 it has undergone many changes. This includes multiple indication expansions to various types of leukemia and lymphoma, approval as a first-line therapy, and even ...
In today’s oncology landscape, new oral chemotherapy medications or updated indications are being released at an increasing rate. With each approval comes new hope for individuals and their families for a road to remission, and also a ...
The American Cancer Society recognizes February as National Cancer Prevention Month. In honor of this month, we are sharing three ways you and your family can help reduce your risk of cancer or detect cancer earlier. Let's start with the simple ...
Avella is your pharmacy partner for oncology medications, Mekinist and Tafinlar, which are now approved for combination therapy. The United States Food and Drug Administration recently approved Mekinist, in combination with Tafinlar, to treat ...
